Literature DB >> 21960753

Overexpression of the progestagen-associated endometrial protein gene is associated with microphthalmia-associated transcription factor in human melanoma.

Suping Ren, Paul M Howell, Ying Han, Jiexi Wang, Minxia Liu, Yan Wang, Guobo Quan, Wei Du, Lei Fang, Adam I Riker.   

Abstract

BACKGROUND: We recently reported that the progestagen-associated endometrial protein (PAEP) gene is overexpressed and promotes tumor proliferation and metastasis in human melanoma.
METHODS: To identify the molecules that regulate its expression and oncogenic properties, we analyzed the gene microarray profiling of melanoma samples of serial clinical stage.
RESULTS: We found that the expression profile of the PAEP gene parallels that of microphthalmia-associated transcription factor (MITF, r  =  0.86), a master regulator of melanocyte development and melanoma progression. This parallelism was further confirmed with semiquantitative reverse transcriptase polymerase chain reaction analysis of melanoma-derived daughter cells. Transfection of melanoma cells with MITF small interfering RNA (siRNA) specifically diminishes PAEP gene expression, whereas PAEP siRNA transfection has no effect on MITF. Furthermore, knockdown of either the MITF or PAEP gene reveals a significant inhibition of tumor cell migration.
CONCLUSIONS: Our data indicate that PAEP expression is regulated in part by MITF and may thus play a role in MITF-mediated cell migration in human melanoma.

Entities:  

Keywords:  Cell migration; gene regulation; melanoma; microphthalmia-associated transcription factor; progestagen-associated endometrial protein

Year:  2011        PMID: 21960753      PMCID: PMC3179191     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  21 in total

1.  Increased glycodelin levels in gynecological malignancies.

Authors:  I R Horowitz; C Cho; M Song; L C Flowers; N Santanam; S Parthasarathy; S Ramachandran
Journal:  Int J Gynecol Cancer       Date:  2001 May-Jun       Impact factor: 3.437

Review 2.  MITF: master regulator of melanocyte development and melanoma oncogene.

Authors:  Carmit Levy; Mehdi Khaled; David E Fisher
Journal:  Trends Mol Med       Date:  2006-08-08       Impact factor: 11.951

3.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

4.  The gene expression signatures of melanoma progression.

Authors:  Christopher Haqq; Mehdi Nosrati; Daniel Sudilovsky; Julia Crothers; Daniel Khodabakhsh; Brian L Pulliam; Scot Federman; James R Miller; Robert E Allen; Mark I Singer; Stanley P L Leong; Britt-Marie Ljung; Richard W Sagebiel; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

5.  c-Met expression is regulated by Mitf in the melanocyte lineage.

Authors:  Gaël G McGill; Rizwan Haq; Emi K Nishimura; David E Fisher
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

6.  Interallelic complementation at the mouse Mitf locus.

Authors:  Eiríkur Steingrímsson; Heinz Arnheiter; Jón Hallsteinn Hallsson; M Lynn Lamoreux; Neal G Copeland; Nancy A Jenkins
Journal:  Genetics       Date:  2003-01       Impact factor: 4.562

7.  Glycodelin in ovarian serous carcinoma: association with differentiation and survival.

Authors:  Erik Mandelin; Heini Lassus; Markku Seppälä; Arto Leminen; Jan-Ake Gustafsson; Guojun Cheng; Ralf Bützow; Riitta Koistinen
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Novel MITF targets identified using a two-step DNA microarray strategy.

Authors:  Keith S Hoek; Natalie C Schlegel; Ossia M Eichhoff; Daniel S Widmer; Christian Praetorius; Steingrimur O Einarsson; Sigridur Valgeirsdottir; Kristin Bergsteinsdottir; Alexander Schepsky; Reinhard Dummer; Eirikur Steingrimsson
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

9.  Glycodelin reduces breast cancer xenograft growth in vivo.

Authors:  Laura C Hautala; Riitta Koistinen; Markku Seppälä; Ralf Bützow; Ulf-Håkan Stenman; Pirjo Laakkonen; Hannu Koistinen
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

10.  Functional characterization of the progestagen-associated endometrial protein gene in human melanoma.

Authors:  Suping Ren; Suhu Liu; Paul M Howell; Guangyu Zhang; Lewis Pannell; Rajeev Samant; Lalita Shevde-Samant; J Allan Tucker; Oystein Fodstad; Adam I Riker
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

View more
  3 in total

1.  Editorial - a potential new target gene of the master-regulator microphthalmia-associated transcription factor in melanoma.

Authors:  Suhu Liu
Journal:  Ochsner J       Date:  2011

Review 2.  The Roles of Glycodelin in Cancer Development and Progression.

Authors:  Juan Cui; Yanguo Liu; Xiuwen Wang
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

3.  Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.

Authors:  Marc A Schneider; Thomas Muley; Nicolas C Kahn; Arne Warth; Michael Thomas; Felix J F Herth; Hendrik Dienemann; Michael Meister
Journal:  Oncotarget       Date:  2016-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.